Nurse Practitioner, Family · Denville, NJ
NPI
1508263989
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
23 Pocono Rd, Suite 100
Denville, NJ, 07834
Phone (973) 316-1701
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.5M
1,116 prescriptions
Company payments, 2025
$1,683
From 27 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jeana Drugac prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 114 prescriptions and refills. In total Jeana Drugac wrote 1,116 Medicare prescriptions that cost $4.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Procrit Epoetin Alfa | 114 | 114 | 46 | $331K |
| Anastrozole Generic | 62 | 118 | 23 | $776 |
| Xarelto Rivaroxaban | 44 | 66 | 16 | $35K |
| Eliquis Apixaban | 44 | 56 | 19 | $32K |
| Jakafi Ruxolitinib Phosphate | 44 | 44 | Under 11 | $634K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 32 | 32 | 21 | $311 |
| Acyclovir Generic | 32 | 38 | Under 11 | $324 |
| Dexamethasone Generic | 32 | 32 | 12 | $525 |
| Neulasta Pegfilgrastim | 31 | 31 | Under 11 | $258K |
| Letrozole Generic | 30 | 64 | 11 | $716 |
| Imbruvica Ibrutinib | 28 | 28 | Under 11 | $456K |
| Hydroxyurea Generic | 24 | 44 | Under 11 | $312 |
| Prochlorperazine Maleate Generic | 22 | 22 | 17 | $290 |
| Prednisone Generic | 21 | 21 | 13 | $125 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 19 | 19 | Under 11 | $224 |
Brand drugs: - claims; generic drugs: 578 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeana Drugac $1,683 ($1,683 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $249.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $249 |
| Daiichi Sankyo Inc. 4568.T | 12 | $226 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $204 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $166 |
| Genzyme Corporation SNY | 5 | $93.72 |
| GlaxoSmithKline, LLC. GSK | 4 | $78.53 |
| Astellas Pharma US Inc 4503.T | 4 | $77.99 |
| Janssen Biotech, Inc. JNJ | 4 | $71.7 |
| Celgene Corporation BMY | 3 | $48.35 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $38.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.